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Abstract
Objectives: Health utility combines health related quality of life and mortality to produce a generic outcome
measure reflecting both morbidity and mortality. It has not been widely used as an outcome measure in
evaluations of emergency care and little is known about the feasibility of measurement, typical values obtained or
baseline factors that predict health utility. We aimed to measure health utility after emergency medical admission,
to compare health utility to age, gender and regional population norms, and identify independent predictors of
health utility.
Methods: We selected 5760 patients across three hospitals who were admitted to hospital by ambulance as a
medical emergency. The EQ-5D questionnaire was mailed to all who were still alive 30 days after admission. Health
utility was estimated by applying tariff values to the EQ-5D responses or imputing a value of zero for those who
had died. Multivariable analysis was used to identify independent predictors of health utility at 30 days.
Results: Responses were received from 2488 (47.7%) patients, while 541 (9.4%) had died. Most respondents
reported some or severe problems with each aspect of health. Mean health utility was 0.49 (standard deviation
0.35) in survivors and 0.45 (0.36) including non-survivors. Some 75% had health utility below their expected value
(mean loss 0.32, 95% confidence interval 0.31 to 0.33) and 11% had health utility below zero (worse than death).
On multivariable modelling, reduced health utility was associated with increased age and lower GCS, varied
according to ICD10 code and was lower among females, patients with recent hospital admission, steroid therapy,
or history of chronic respiratory disease, malignancy, diabetes or epilepsy.
Conclusions: Health utility can be measured after emergency medical admission, although responder bias may be
significant. Health utility after emergency medical admission is poor compared to population norms. We have
identified independent predictors or health utility that need to be measured and taken into account in non-
randomized evaluations of emergency care.
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Background
Patient outcomes need to be measured after emergency
medical care for research, quality improvement and
benchmarking of performance [1]. Mortality is widely
used as an outcome measure in research, and risk-adjusted
mortality can be used to compare systems of emergency
care and drive quality improvement [2,3]. Health related
quality of life, by contrast, is less commonly used as an
outcome measure in emergency medicine research and
has rarely been used in quality improvement [4-7].
However, some important emergency interventions, such
as thrombolysis for stroke [8], affect health related quality
of life rather than mortality. The impact of these interven-
tions will only be identified if we measure health related
quality of life.
Health related quality of life has been measured after
hospital admission for major trauma [9-11] and specific ill-
nesses, such as myocardial infarction [12] and stroke [13].
Major trauma is only responsible for a small proportion of
emergency hospital admissions. Most admissions are for
medical conditions, with patients increasingly presenting
with mixed pathologies and multiple co-morbidities. We
need to measure health related quality of life in the general
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emergency medical population if we are to estimate the
effect of interventions and changes in service delivery
upon the whole relevant population.
If both mortality and health related quality of life are
measured then these can be combined to provide an
overall measure of health, known as health utility. This
measure allows comparison of outcomes between a wide
range of different conditions and interventions affecting
both mortality and morbidity. Combining mortality and
health related quality of life in a single measure also over-
comes a problem inherent in measuring quality of life
alone, the “healthy survivor effect”, whereby an apparent
improvement in health related quality of life may be
caused by an increase in mortality among patients with
lower quality of life. However, health utility has not been
widely used as an outcome measure in evaluations of
emergency care and little is known about the feasibility
of measurement, typical values obtained or baseline fac-
tors that predict health utility.
Health utility among emergency medical patients will
clearly be influenced by many factors, especially pre-exist-
ing co-morbidities, and emergency treatment will be only
one factor influencing outcome. Baseline measurement of
health related quality of life (i.e. prior to emergency care)
is subject to substantial logistical barriers and likely to be
unfeasible or impractical for most evaluations, so any non-
randomized evaluation of emergency care using health uti-
lity as an outcome needs to measure and take into account
factors that predict health utility after emergency care. We
therefore need to know which covariates predict health
utility after emergency medical care, as well as knowing
whether measurement is feasible, before health utility can
become a widely-used outcome measure for emergency
care.
This study was undertaken as part of the DAVROS
study (Development And Validation of Risk-adjusted Out-
comes for Systems of emergency care) and aimed to evalu-
ate the use of health utility as an outcome measure in
emergency care. Our specific objectives were to compare
health utility of the population to region, age and gender
adjusted normal values and to identify independent pre-
dictors of health utility. We did not aim to compare ser-
vices in this evaluation or draw inferences about the effect
of emergency health care upon health utility.
Methods
We undertook a cross-sectional survey to measure health
utility among patients recently admitted to hospital with
a medical emergency using the EQ-5D self-complete
questionnaire. We valued health utility using the EQ-5D
for survivors and attributed a value of zero to those who
had died by 30 days. The EQ-5D was developed following
a review of existing generic health measures and consists
of 5 questions relating to health status over the previous
day [14,15]. The responses to the 5 questions allow
patients to be classified into one of 243 possible health
states. These health states were valued using preferences
derived from the piloting of the questionnaire to produce
a tariff for each state [15-17]. The tariff values overall
health on a scale in which zero equates to death and one
equates to perfect health. Negative values (health states
worse than death) are possible.
The study took place in three emergency departments in
Sheffield, Barnsley and Rotherham in South Yorkshire in
the United Kingdom and in the Yorkshire Ambulance Ser-
vice. These three emergency departments provide adult
emergency services to a largely urban population of
around 1 million. Patients were identified by review of
hospital computer systems and selected if they were (a)
alive and not in cardiac arrest when attended by an emer-
gency ambulance, and (b) were then either admitted to
hospital or died in the ambulance or emergency depart-
ment. We excluded children (aged < 18 years), women
with obstetric emergencies, adults with primarily mental
health emergencies and injured adults aged under 65. We
felt that these patients would have markedly different
health utility from the majority of emergency medical
admissions and/or would present particular difficulties in
measurement. The threshold of 65 years for injuries was
chosen as a crude means of including those with injuries
likely to be secondary to or associated with medical com-
plaints, while excluding those with primarily traumatic
reasons for admission.
Hospital computer records and local Coroner’s Office
lists of deaths were checked 30 days after patient admis-
sion and any patient not recorded as being dead was sent
a letter from the emergency department inviting them to
take part in the research, along with an information
sheet, consent form and copy of the EQ-5D question-
naire. If they were willing to participate they signed the
consent form, completed the EQ-5D and mailed both to
the University of Sheffield in a postage-paid envelope.
They were asked to return the uncompleted question-
naire if they did not wish to participate. A single remin-
der was mailed two weeks after the initial mailing to
non-responders.
Emergency department data, including patient age,
gender, physiology (heart rate, respiratory rate, blood
pressure, peripheral oxygen saturation and Glasgow
Coma Score (GCS)), recorded co-morbidities and hospi-
tal admission within the previous 30 days, were
abstracted from computer and paper hospital records by
a researcher. Ambulance physiology data were recorded
by paramedics on the standard patient report forms and
then scanned onto an electronic database. Ambulance
data were then matched to emergency department data
using the ambulance dispatch code. Wherever possible
the first physiological recording (i.e. the ambulance
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recording) was used. Where no physiology was recorded
in the ambulance or the cases could not be matched to
the patient report form the emergency department phy-
siology data were used. Each patient had an International
Classification of Diseases version 10 (ICD-10) code
attributed by hospital clerical staff as part of routine
management. All data were entered onto a secure online
database managed by the University of Sheffield Clinical
Trials Unit.
Chi-square tests were used to test the association
between baseline patient characteristics (age group, gen-
der, ICD-10 code, hospital admission within the previous
30 days, recorded co-morbidities and hospital attended)
and questionnaire response rate. Patients who had died
by 30 days were attributed health utility of zero. Patients
who had died effectively had a response rate of 100%
whereas those who survived had a lower response rate.
To account for this differential rate of missing data we
upweighted the EQ-5D scores of questionnaire respon-
dents by the inverse of the age- and sex- specific response
rate. All analyses used the weighted scores. Health utility
data for the normal United Kingdom population were
used to calculate a regional, age and gender adjusted
expected normal value for each patient [17]. Analysis of
variance was used to test the association between base-
line patient characteristics and health utility, and also
between physiological variables and health utility. Finally
multivariable linear regression was used to determine
independent predictors of health utility. Continuous cov-
ariates were categorised for the purpose of displaying
univariate associations and assessing linearity, but were
included as continuous in the multivariable model. Func-
tional form was assessed using fractional polynomials
[18]. Missing data was handled by performing multiple
imputation in which the candidate explanatory factors
previously described were imputed on the basis of each
other using chained imputation [19]. Reported results are
based on multiple imputation results and the presented
model is the averaged results from 50 imputations. All
analyses were undertaken using Stat version 11 (Stata
Statistical Software: Release 11. College Station, TX:
StataCorp LP. 2009).
The study protocol was approved by the Leeds East
Research Ethics Committee (reference 07/Q1206/24).
Results
We identified 2427 eligible cases between 11 February
2008 and 5 May 2008 in Sheffield, 1673 cases between 19
November 2007 and 24 February 2008 in Barnsley and
1660 cases between 19 November 2007 and 25 February
2008 in Rotherham. Out of the total of 5760 cases, 541
(9.4%) were identified as having died by 30 days after
attendance: 519 were identified from the hospital compu-
ter system with no additional cases from local Coroner’s
records, while 22 were identified after relatives returned
the questionnaire or contacted us following inadvertent
mailing of someone who had died. Completed question-
naires were received from 2488 patients (47.7% of those
alive at 30 days), while 71 patients declined to participate
by returning an empty questionnaire and the remainder
did not respond.
Table 1 shows the proportion of patients who had died
by 30 days after hospital attendance and the proportion
of those mailed who responded, according to baseline
patient characteristics. The response rate was lowest
among the youngest and oldest, and highest in the 60-69
year group. Patients diagnosed with diseases of the circu-
latory system, musculoskeletal system or nervous system
had higher response rates while those diagnosed with dis-
eases of the skin and subcutaneous tissue, endocrine,
nutritional and metabolic diseases, mental and beha-
vioural disorders or neoplasms had lower response rates.
Patients with a history of chronic respiratory disease or
heart disease, and those on long-term steroid or warfarin
therapy had higher response rates than those without
these co-morbidities.
Table 2 shows the responses to each EQ-5D question.
Most respondents reported at least some problems with
each aspect of health and only about one in four were
able to perform their usual activities or free from pain
or discomfort.
Figure 1 shows health utility for the population and
Figure 2 shows health utility compared to regional age
and gender adjusted norms. Dead patients are included
in these figures with a health utility of zero while values
derived from the survey are weighted to allow for non-
response. In both figures the dead patients are shaded in
pale gray while the survivors are dark gray. Health utility
was generally poor compared to age and gender adjusted
regional norms. A substantial proportion of patients had
health utility well below normal values (75% of patients
had health utility below their normal value; mean loss
0.32, 95% CI 0.31 to 0.33) and a significant proportion
(11%) had health utility below zero.
Mean health utility among survivors was 0.49 (standard
deviation 0.35) while mean health utility in the whole
cohort (i.e. including non-survivors) was 0.45 (0.36).
Table 3 shows the association between patient character-
istics and health utility. Mean health utility was lower in
women, older patients and those with a recent hospital
admission, recorded co-morbidities, neoplasms, diseases
of the musculoskeletal system and connective tissue, dis-
eases of the skin and subcutaneous tissue, diseases of the
respiratory system, on steroid therapy and with abnormal
physiological values or systolic blood pressure < 120
mmHg at presentation. On multivariable modelling
(Table 4) health utility was reduced with increased age
and lower GCS, varied according to ICD-10 and was
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Table 1 Death and response rate in relation to patient characteristics






Overall 5760 541 (9.4%) 2487 (47.7%)
Gender 0.400
Females 2995 279 (9.3%) 1273 (46.9%)
Males 2710 255 (9.4%) 1193 (48.6%)
Age < 0.001
Under 30 355 2 (0.6%) 108 (30.6%)
30-39 368 4 (1.1%) 117 (32.1%)
40-49 504 4 (0.8%) 200 (40.0%)
50-59 516 19 (3.7%) 258 (51.9%)
60-69 823 69 (8.4%) 440 (58.4%)
70-79 1301 137 (10.5%) 636 (54.6%)
80-89 1441 219 (15.2%) 594 (48.6%)
90 or above 422 82 (19.4%) 122 (35.9%)
Centre < 0.001
Barnsley 1673 127 (7.6%) 779 (50.4%)
Rotherham 1660 188 (11.3%) 733 (49.8%)
Sheffield 2427 226 (9.3%) 975 (44.3%)
Hospital admission within the last 30 days 0.007
Yes 879 93 (10.6%) 361 (45.9%)
No 2734 259 (9.5%) 1138 (46.0%)
Unknown 2147 189 (8.8%) 988 (50.5%)
ICD-10 code** < 0.001
Certain infectious and parasitic diseases 118 24 (20.3%) 47 (50.0%)
Diseases of the circulatory system 1074 148 (13.8%) 506 (54.6%)
Diseases of the digestive system 530 29 (5.5%) 228 (45.5%)
Diseases of the genitourinary system 296 22 (7.4%) 114 (41.6%)
Diseases of the musculoskeletal system and connective tissue 114 1 (0.9%) 59 (52.2%)
Diseases of the nervous system 180 6 (3.3%) 94 (54.0%)
Diseases of the respiratory system 1060 174 (16.4%) 451 (50.9%)
Diseases of the skin and subcutaneous tissue 50 4 (8.0%) 12 (26.1%)
Endocrine, nutritional and metabolic diseases 96 4 (4.2%) 32 (34.8%)
Injury, poisoning and certain other consequences of external causes 845 47 (5.6%) 339 (42.5%)
Mental and behavioural disorders 120 4 (3.3%) 42 (36.2%)
Neoplasms 110 46 (41.8%) 23 (35.9%)
Symptoms, signs and abnormal clinical and laboratory findings, not
elsewhere classified
1088 24 (2.2%) 508 (47.7%)
Other 60 2 (3.3%) 29 (50.0%)
Unknown 19 6 (31.6%) 3 (23.1%)
History of chronic respiratory disease 746 96 (12.9%) 359 (55.2%) < 0.001
History of heart disease 1902 211 (11.1%) 898 (53.1%) < 0.001
History of active malignancy 266 84 (31.6%) 86 (47.3%) 0.91
History of asthma 661 44 (6.7%) 291 (47.2%) 0.792
History of diabetes 896 79 (8.8%) 399 (48.8%) 0.464
History of epilepsy 235 18 (7.7%) 94 (43.3%) 0.192
On warfarin therapy 319 33 (10.3%) 180 (62.9%) < 0.001
On steroid therapy 296 44 (14.9%) 146 (57.9%) < 0.001
* excluding deaths within 30 days
**primary discharge diagnosis
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lower among females, patients with recent hospital
admission, on steroid therapy, or history of any of
chronic respiratory disease, malignancy, diabetes and epi-
lepsy. Other variables, most notably the physiological
variables heart rate, respiratory rate, peripheral oxygen
saturation and blood pressure, were not significant pre-
dictors of health utility in multivariate analysis.
Discussion
To our knowledge, this is the first study to measure health
utility in an unselected cohort of patients after emergency
medical admission. We found that health utility was mark-
edly below regional age and gender adjusted norms and
11% of the population had health utility below zero. Mea-
surement of mortality alone is inadequate in evaluating
emergency medical treatments and services. If survivors
have severely impaired health related quality of life then
the value of interventions that improve survival alone may
be open to question.
We identified patient characteristics that independently
predicted health utility. Older patients, women, those with
a low presenting GCS and those with recent hospital
admission, on steroid therapy, or history of any of chronic
respiratory disease, malignancy, diabetes or epilepsy had
lower health utility. Non-randomized research and
performance indicators measuring health utility should, if
possible, measure and adjust for these covariates in analy-
sis. Other baseline measures (heart rate, respiratory rate
and blood pressure) were associated with health utility but
were not independent predictors on multivariate analysis.
These are potentially helpful findings because they indicate
that the main independent predictors of health utility, with
the exception of GCS, are likely to be routinely available
and relatively easy to record for observational research.
Additional efforts to record baseline physiology, with the
exception of GCS, are unlikely to represent a worthwhile
use of resources. However, it should be recognised that
some of the factors were also associated with response
rate. The estimated association between patient character-
istics and health utility may therefore be influenced by
responder bias. Furthermore, the R-squared statistic for
the model (12.6%), whilst not especially low in the biome-
dical setting, suggests that the variables we identified only
explain a modest proportion of variability. Examination of
other co-morbidities, particularly those affecting mobility
and mental health, could help to explain variability in
health utility.
We deliberately selected a diverse sample. Emergency
medical admissions include a substantial proportion of
patients with ill-defined complaints or multiple morbid-
ities, as reflected by the large group in our cohort with
unclassified diagnoses. Including these patients is impor-
tant to ensure a truly representative sample and atten-
tion is not focussed upon those with clearly defined
single pathologies, but this can make it more difficult to
draw inferences about the effects of intervention, if
health utility data are used for this purpose.
Comparison of our data to previous studies of specific
patient groups is complicated by differences in the tim-
ing of measurement, with most studies measuring health







Mobility 701 (28%) 1682 (68%) 104 (4%)
Self care 1256 (50%) 1041 (42%) 190 (8%)
Usual activities 604 (24%) 1290 (52%) 593 (24%)
Pain/discomfort 552 (22%) 1517 (61%) 418 (17%)
Anxiety/
depression
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Figure 1 Health utility of the study population. Survivors are
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Figure 2 Health utility loss compared to age and gender
adjusted regional norms. Survivors are shaded in dark gray, dead
patients in pale gray.
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Table 3 Health utility estimates stratified by patient characteristics
Factor N N dead Mean SD Median p
Overall 3028 541 0.45 0.36 0.52
Gender < 0.001
Females 1552 279 0.43 0.36 0.52
Males 1448 255 0.48 0.37 0.59
Age < 0.001
Under 30 110 2 0.65 0.38 0.76
30-39 121 4 0.58 0.37 0.69
40-49 204 4 0.53 0.40 0.69
50-59 277 19 0.47 0.36 0.59
60-69 509 69 0.45 0.37 0.52
70-79 773 137 0.43 0.35 0.52
80-89 813 219 0.40 0.34 0.52
90 or above 204 82 0.29 0.30 0.25
Centre 0.071
Barnsley 906 127 0.47 0.36 0.59
Rotherham 921 188 0.44 0.36 0.52
Sheffield 1201 226 0.44 0.37 0.52
Previous hospital admission < 0.001
Yes 454 93 0.35 0.36 0.29
No 1397 259 0.46 0.37 0.52
Unknown 1177 189 0.48 0.36 0.59
ICD-10 code < 0.001
Certain infectious and parasitic diseases 71 24 0.43 0.41 0.52
Diseases of the circulatory system 654 148 0.46 0.36 0.56
Diseases of the digestive system 257 29 0.53 0.36 0.62
Diseases of the genitourinary system 136 22 0.43 0.39 0.52
Diseases of the musculoskeletal system and connective tissue 60 1 0.33 0.34 0.52
Diseases of the nervous system 100 6 0.51 0.36 0.59
Diseases of the respiratory system 625 174 0.39 0.37 0.38
Diseases of the skin and subcutaneous tissue 16 4 0.36 0.38 0.52
Endocrine, nutritional and metabolic diseases 36 4 0.63 0.34 0.69
Injury, poisoning and certain other consequences of external causes 386 47 0.43 0.34 0.52
Mental and behavioural disorders 46 4 0.46 0.36 0.52
Neoplasms 69 46 0.18 0.33 0.00
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified 532 24 0.50 0.35 0.59
Other 31 2 0.55 0.35 0.59
Unknown 9 6 0.41 0.47 0.19
History of chronic respiratory disease 455 96 0.32 0.32 0.29 < 0.001
History of heart disease 1109 211 0.41 0.34 0.52 < 0.001
History of active malignancy 170 84 0.29 0.35 0.19 < 0.001
History of asthma 335 44 0.41 0.36 0.52 0.048
History of diabetes 478 79 0.40 0.35 0.52 0.003
History of epilepsy 112 18 0.39 0.38 0.52 0.074
On warfarin therapy 213 33 0.41 0.34 0.52 0.126
On steroid therapy 190 44 0.30 0.33 0.26 < 0.001
Glasgow coma scale < 0.001
< = 8 111 67 0.24 0.36 0.03
9-12 126 61 0.34 0.37 0.25
13-15 2706 384 0.47 0.36 0.58
Missing 85 29 0.32 0.33 0.36
Oxygen saturation (%) < 0.001
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utility later than 30 days after admission, and previous
studies limiting analysis to survivors. Even allowing for
these differences our study suggests that at 30 days
unselected emergency medical admissions, with a mean
EQ-5D score among survivors of 0.49 (median 0.59),
have worse health utility than patients suffering major
trauma (median EQ-5D 0.73 at one year [9], mean 0.69
at 12-18 months [10]), stroke (mean 0.62 at 6 months
[13]) or myocardial infarction (median 0.73 at 2 to 25
months [12]).
Our findings suggest that measuring health utility after
emergency admission is feasible and potentially worth-
while. The response rate of 48% is sufficient for mean-
ingful analysis and relatively high for an unsolicited
mailing to an unselected sample, but carries a significant
risk of responder bias. We have identified a number of
factors that predict questionnaire response and need to
be considered when planning future research. Although
most deaths were identified though hospital systems we
inadvertently mailed questionnaires to 22 patients who
had died within 30 days. This risk was discussed with
the ethics committee before the study and accepted as
inevitable. However, inadvertent mailing to a deceased
person has the potential to cause distress and should be
taken into account when measuring health status.
An important implication of our study is that evalua-
tions of emergency care, whether research or audit, that
measure mortality without attempting to measure health
related quality of life may fail to measure the true value
of emergency care. Health utility after emergency admis-
sion is typically lower than age, gender and regional
norms, and severely reduced in a substantial proportion.
Our study has a number of limitations. Only about
half of the population responded and completed the
questionnaire. We identified a number of factors pre-
dicting response which suggested that response was
more likely among those aged 60-69 and those with co-
morbidities, perhaps because these patients are more
likely to be engaged in ongoing medical care. However,
it is not clear what effect this bias will have on estimates
of overall health utility.
The EQ-5D is a validated and widely used measure of
health status, but when using the questionnaire patients
do not directly value their health utility. Instead it is cal-
culated using tariff values applied to the ratings they
indicate on five dimensions of health. This means that
the estimate of health utility generated by the EQ-5D
for an individual may not equate to that individual’s per-
ception of their health status. This means that when the
EQ-5D generates an estimate of less than zero for health
utility we cannot assume that the individual rates their
health status as being worse than death, only that their
health status has been rated during EQ-5D validation as
being worse than death. Furthermore, a single measure-
ment at 30 days after hospital admission may represent
a temporary state, associated with pain or loss of mobi-
lity for example, and should not be interpreted as a life
not worth saving. Our study does not provide data on
Table 3 Health utility estimates stratified by patient characteristics (Continued)
> 93(air)/> 98(O2) 1913 206 0.48 0.36 0.59
90-93(air)/94-98(O2) 541 120 0.42 0.36 0.52
< 90(air)/< 94(O2) 472 175 0.36 0.36 0.29
Missing 102 40 0.35 0.37 0.36
Systolic blood pressure (mmHg) 0.002
120-180 1967 274 0.46 0.36 0.58
> 180 364 48 0.46 0.35 0.59
100-119 365 104 0.42 0.37 0.52
< 100 274 95 0.40 0.38 0.52
Missing 58 20 0.31 0.36 0.36
Heart rate (per minute) 0.003
60-100 1874 287 0.46 0.36 0.55
101-130 745 153 0.42 0.37 0.52
> 130 168 51 0.43 0.38 0.52
< 60 188 33 0.51 0.37 0.62
Missing 53 17 0.33 0.36 0.36
Respiratory rate (per minute) < 0.001
10-25 2359 329 0.48 0.36 0.59
> 25 525 170 0.37 0.37 0.29
< 10 13 5 0.25 0.38 0.08
Missing 131 37 0.34 0.35 0.36
Note: responders alive at 30 days are upweighted by the inverse of the age & gender specific response rate
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health changes after emergency medical admission or
allow comparison to a control group, so we cannot
draw inferences regarding the effectiveness or otherwise
of the care provided.
The data presented in Figure 2 showing deviation
from population norms should be interpreted with cau-
tion. The data are presented in this way to allow us to
take into account population norms and should not be
used to draw inferences about the quality of local emer-
gency care or the implications of our findings for speci-
fic individuals. The cases with extreme values, in
particular, may simply represent random variation with
some people rating their health as good despite a low
age and gender predicted value (and vice versa).
Finally, identifying patient characteristics that predict
questionnaire response and health utility involved multi-
ple hypothesis testing with the associated risk of spur-
ious chance findings. We did not adjust statistical
significance to account for multiple testing so would
urge caution in interpreting findings with p-values
between 0.05 and 0.01.
Conclusion
Health utility can be measured after emergency medical
admission, although responder bias may be significant.
Health utility after emergency medical admission is poor
compared to population norms. We have identified
independent predictors or health utility that need to be
measured and taken into account in non-randomized
evaluations of emergency care. Further research is
required to determine whether the findings of our study
can be reproduced in other regions, countries and emer-
gency care settings. Research is also required to identify
reasons for non-response, to determine how responder
bias may influence estimates of health utility and to
explore methods to improve questionnaire response in
this setting.
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Table 4 Multivariable analysis of factors associated with health utility (EQ-5D score)
Beta 95% CI p
Factor
Gender (male v female) 0.049 0.016, 0.082 0.003
Previous hospital admission within 30 days (yes v no) -0.101 -0.138, -0.064 < 0.001
ICD-10 code
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Diseases of the circulatory system 0.043 -0.066, 0.151
Diseases of the digestive system 0.119 0.003, 0.235
Diseases of the genitourinary system -0.007 -0.133, 0.120
Diseases of the musculoskeletal system and connective tissue -0.091 -0.238, 0.057
Diseases of the nervous system 0.127 -0.009, 0.263
Diseases of the respiratory system 0.053 -0.056, 0.163
Diseases of the skin and subcutaneous tissue -0.275 -0.526, -0.023
Endocrine, nutritional and metabolic diseases 0.180 0.011, 0.348
Injury, poisoning and certain other consequences of external causes -0.012 -0.123, 0.100
Mental and behavioural disorders -0.014 -0.165, 0.137
Neoplasms -0.091 -0.253, 0.072
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified 0.085 -0.024, 0.194
Other 0.128 -0.042, 0.298
Unknown
History of chronic respiratory disease -0.094 -0.144, -0.043 < 0.001
History of active malignancy -0.111 -0.190, -0.032 0.006
History of diabetes -0.072 -0.118, -0.026 0.002
History of epilepsy -0.101 -0.186, -0.016 0.021
On steroid therapy -0.105 -0.169, -0.041 0.001
Age * < 0.001
Glasgow coma scale * < 0.001
* EQ5D was reduced with increased age and lower GCS; both were monotonic but non-linear decreases for which a quadratic model produced an adequate fit,
Age: Fitted line is -0.0015*Age-0.000018*Age2, GCS: Fitted line is 0.0043*GCS +0.000852*GCS2
R-squared statistic for the model = 12.6%.
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